In order to create a holistic experience to reframe the cancer patient pathway, it is necessary to detect and measure psychological and emotional distress as early as possible.
A new thought leadership paper has been published, based on a study conducted by iWantGreatCare and Siemens Healthineers into the range of emotions experienced by patients on breast and prostate cancer pathways.
Co-authored by iWantGreatCare's Chief Knowledge Officer, Sir Muir Gray, and part of the Siemens Healthineers Insights Series, the paper proposes an easily applicable approach for early detection of stress, anxiety, and emotional distress, along the entire cancer pathway, using digital resources in connection with medical technology.
It proposes a systematic application of integrated therapies to improve clinical outcomes and the well-being of patients. It also highlights the collaboration of healthcare providers, the medical technology industry, individuals, the oncological disciplines of radiology, radiotherapy and chemotherapy that are required for this revolution for integrated care to become a reality globally.
More than half of patients diagnosed with cancer suffer from moderate to severe anxiety, emotional distress and depression. This has a direct impact on the efficiency of diagnosis and treatment, the overall patient experience, and patient outcomes. It is estimated that 50% to 60% of anxiety and depression go unrecognized. Healthcare workflows are severely impacted as a result.
To learn more and download a free copy of the paper, visit the following link: